PMID- 32599929 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200928 IS - 2072-6694 (Print) IS - 2072-6694 (Electronic) IS - 2072-6694 (Linking) VI - 12 IP - 6 DP - 2020 Jun 24 TI - Role of Colposcopy after Treatment for Cervical Intraepithelial Neoplasia. LID - 10.3390/cancers12061683 [doi] LID - 1683 AB - Colposcopy is often used in follow-up after treatment for cervical intraepithelial neoplasia (CIN) despite its marked inter-observer variability and low sensitivity. Our objective was to assess the role of colposcopy in post-treatment follow-up in comparison to hrHPV (high-risk human papillomavirus) testing, cytology, and cone margin status. Altogether, 419 women treated for histological high-grade lesion (HSIL) with large loop excision of the transformation zone (LLETZ) attended colposcopy with cytology and hrHPV test at six months. Follow-up for recurrence of HSIL continued for 24 months. Colposcopy was considered positive if colposcopic impression was recorded as high grade and cytology if HSIL, ASC-H (atypical squamous cells, cannot exclude HSIL), or AGC-FN (atypical glandular cells, favor neoplasia) were present. Overall, 10 (10/419, 2.4%) recurrent HSIL cases were detected, 5 at 6 months and 5 at 12 months. Colposcopic impression was recorded at 407/419 6-month visits and was positive for 11/407 (2.7%). None of them had recurrent lesions, resulting in 0% sensitivity and 97% specificity for colposcopy. Sensitivity for the hrHPV test at 6 months was 100% and specificity 85%, for cytology 40% and 99%, and for margin status at treatment 60% and 82%, respectively. While the hrHPV test is highly sensitive in predicting recurrence after local treatment for CIN, colposcopy in an unselected population is not useful in follow-up after treatment of CIN. FAU - Heinonen, Annu AU - Heinonen A AD - Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland. FAU - Jakobsson, Maija AU - Jakobsson M AD - Department of Obstetrics and Gynecology, Hyvinkaa Hospital, HUCH and University of Helsinki, 05850 Hyvinkaa, Finland. FAU - Kiviharju, Mari AU - Kiviharju M AD - Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland. FAU - Virtanen, Seppo AU - Virtanen S AD - Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland. FAU - Aro, Karoliina AU - Aro K AD - Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland. FAU - Kyrgiou, Maria AU - Kyrgiou M AD - Department of Gut, Metabolism and Reproduction & Department of Surgery and Cancer, Institute of Reproductive and Developmental Biology, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK. AD - West London Gynaecological Cancer Centre, Imperial College Healthcare NHS Trust, London W2 1NY, UK. FAU - Nieminen, Pekka AU - Nieminen P AD - Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland. FAU - Kalliala, Ilkka AU - Kalliala I AUID- ORCID: 0000-0002-7664-0587 AD - Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland. AD - Department of Gut, Metabolism and Reproduction & Department of Surgery and Cancer, Institute of Reproductive and Developmental Biology, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK. LA - eng GR - TYH2019241/Helsingin ja Uudenmaan Sairaanhoitopiiri/ GR - TYH 2020401/Helsingin ja Uudenmaan Sairaanhoitopiiri/ GR - ./Emil Aaltosen Saatio/ GR - ./Paulon Saatio/ GR - ./Suomen Laaketieteen Saatio/ GR - ./Jalmari ja Rauha Ahokkaan Saatio/ GR - ./Academy of Finland/ PT - Journal Article DEP - 20200624 PL - Switzerland TA - Cancers (Basel) JT - Cancers JID - 101526829 PMC - PMC7352967 OTO - NOTNLM OT - CIN OT - colposcopy OT - follow-up OT - test of cure COIS- The authors declare no conflict of interest. EDAT- 2020/07/01 06:00 MHDA- 2020/07/01 06:01 PMCR- 2020/06/24 CRDT- 2020/07/01 06:00 PHST- 2020/05/16 00:00 [received] PHST- 2020/06/13 00:00 [revised] PHST- 2020/06/18 00:00 [accepted] PHST- 2020/07/01 06:00 [entrez] PHST- 2020/07/01 06:00 [pubmed] PHST- 2020/07/01 06:01 [medline] PHST- 2020/06/24 00:00 [pmc-release] AID - cancers12061683 [pii] AID - cancers-12-01683 [pii] AID - 10.3390/cancers12061683 [doi] PST - epublish SO - Cancers (Basel). 2020 Jun 24;12(6):1683. doi: 10.3390/cancers12061683.